🔎 Trials Near Me

Почетна › Беркитов лимфом › Пенсилванија › Philadelphia

Kliničke studije za Беркитов лимфом u gradu Philadelphia, PA

15 studija za Беркитов лимфом traži učesnike na lokacijama u gradu Philadelphia i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Тражи се учесникФаза 1
  • Children's Hospital of Philadelphia, Philadelphia
Узраст од 0 до 18 · Оба пола · Ажурирано 13. 11. 2026. · NCT06173518

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 ми удаљено
Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Тражи се учесникФаза 3
  • Children's Hospital of Philadelphia, Philadelphia
Узраст 1 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07223021

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Тражи се учесникФаза 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Узраст од 18 до 39 · Оба пола · Ажурирано 3. 11. 2026. · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT06395103

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Тражи се учесникОпсервациона студија
  • Children's Hospital of Philadelphia, Philadelphia
Узраст од 0 до 38 · Оба пола · Ажурирано 29. 10. 2026. · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 ми удаљено
365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 ми удаљено
366 Days – 46 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06124157

Blinatumomab Consolidation in Real World

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • University of Pennsylvania, Philadelphia
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT07117136

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 ми удаљено
365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Тражи се учесникФаза 2
  • Children's Hospital of Philadelphia, Philadelphia
Узраст од 7 до 25 · Оба пола · Ажурирано 19. 8. 2026. · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Тражи се учесник
  • Children's Hospital of Philadelphia, Philadelphia
До 25 година · Оба пола · Ажурирано 8. 7. 2026. · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Тражи се учесникФаза 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Узраст од 0 до 29 · Оба пола · Ажурирано 26. 5. 2026. · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

Тражи се учесникФаза 1/2
  • Children's Hospital of Philadelphia, Philadelphia
До 29 година · Оба пола · Ажурирано 27. 3. 2026. · NCT05674175

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Тражи се учесникФаза 2
  • Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25 ми удаљено
Узраст од 1 до 25 · Оба пола · Ажурирано 4. 5. 2025. · NCT03509961

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu Philadelphia

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.